| Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models |
Globe Newswire |
05/21 |
17:01 |
| ALDX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX |
Globe Newswire |
05/21 |
17:01 |
| AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit |
Globe Newswire |
05/21 |
17:00 |
| Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting |
Globe Newswire |
05/21 |
17:00 |
| HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccRCC) at the Upcoming 2026 ASCO Annual Meeting |
Globe Newswire |
05/21 |
17:00 |
| Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting |
Globe Newswire |
05/21 |
17:00 |
| BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2026 ASCO Annual Meeting |
Globe Newswire |
05/21 |
17:00 |
| Legend Biotech Announces Presentations at ASCO 2026 |
Globe Newswire |
05/21 |
17:00 |
| Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline |
Globe Newswire |
05/21 |
17:00 |
| Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy |
Globe Newswire |
05/21 |
17:00 |
| Zodiac Partners II, LLC Provides an Update to its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash |
Globe Newswire |
05/21 |
17:00 |
| TruGolf Reports First Quarter 2026 Results |
Globe Newswire |
05/21 |
17:00 |
| Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC |
Globe Newswire |
05/21 |
17:00 |
| Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting |
Globe Newswire |
05/21 |
17:00 |
| Backlash to Trump's $1.8B settlement fund delays GOP immigration bill |
AP Online |
05/21 |
16:51 |
| The Math Underlying the Success of Tort Reforms – Florida Property Insurance and Beyond |
Globe Newswire |
05/21 |
16:45 |
| AMSC to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 27, 2026 |
Globe Newswire |
05/21 |
16:45 |
| ROSEN, SKILLED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC |
Globe Newswire |
05/21 |
16:43 |
| Brazilian grieving father says justice still missing after Airbus, Air France guilty verdict |
AP Online |
05/21 |
16:35 |
| ROSEN, THE FIRST FILING FIRM, Encourages POET Technologies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – POET |
Globe Newswire |
05/21 |
16:35 |
| THRiYV Expands Nootropic Energy Line, Delivering a Cleaner Alternative to Nicotine Pouches & Energy Drinks |
Globe Newswire |
05/21 |
16:33 |
| Kadant Authorizes Share Repurchase |
Globe Newswire |
05/21 |
16:32 |
| ROHM Launches ESD Protection Diodes for High-Speed Interfaces Exceeding 10 Gbps |
Globe Newswire |
05/21 |
16:30 |
| [Latest] Global Private 5G Network Market to Reach USD 312.2 Billion by 2035, Expanding at a 52.8% CAGR, Says Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) |
Globe Newswire |
05/21 |
16:30 |
| Hub Group Receives Expected Deficiency Notice from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q |
Globe Newswire |
05/21 |
16:30 |
